EUVIMEDEUVIMED entdecken
Crossref

T reg cells promote immunotherapy-induced immune evasion by restraining CD4 T cell control of MHC-I–deficient metastatic pancreatic cancer

Zoe C Schmiechen iD, Eduardo Cruz-Hinojoza iD, Audrey L Hilk iD, Madeline A Ellefson, Alexander K Tsai iD, Olivia M Dres iD, Liang-I Kang iD, Michael J Geuenich iD, Jonah Z Butler iD, Adam L Burrack iD, Brandon M Larsen, Grant H Hickok iD und 12 weitere

Science Immunology · 26.06.2026 · 11 (120)

DOI: 10.1126/sciimmunol.adz4302 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Immunology, erschienen am 26.06.2026. Verfasst von Zoe C Schmiechen und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, University of Minnesota Medical School, Minneapolis, MN, USA. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Pancreatic Neoplasms, Immunotherapy, Histocompatibility Antigens Class I. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 109 Literaturangaben. Gefördert von: NIGMS NIH HHS, National Institutes of Health, AACR-Pancreatic Action Network.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mechanisms driving immunotherapy resistance in pancreatic cancer are poorly defined. We demonstrate that programmed death-ligand 1 immune checkpoint blockade promoted immune evasion by epigenetic Tap1 ( transporter associated with antigen processing 1 ) silencing, increasing selection of metastatic tumor variants with defective interferon-γ (IFN-γ)–inducible class I major histocompatibility complex (MHC-I) expression. Unleashing CD4 conventional T cells by regulatory T cell (T reg cell) depletion, transfer of tumor-reactive CD4 T cells, or anti–CTLA-4 prevented metastasis. Tumor-specific CD4 T cells adopted a TCF-1 + SLAMF6 + progenitor state in lymph nodes and differentiated in tumors. Anti–CTLA-4 increased intratumoral accumulation of CD4 T cells with stemness and tissue residency features, reduced metastasis, and induced gene signatures correlated with improved patient outcomes. MHC-I restoration with anti–CTLA-4 prolonged survival in murine models. In patient tumors, T reg cells and CD4 T cells colocalized, and abundance correlated with survival. These findings identify targetable mechanisms of immune evasion and metastasis in immunotherapy-resistant cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

T-Lymphocytes, RegulatoryPancreatic NeoplasmsImmunotherapyHistocompatibility Antigens Class ICD4-Positive T-LymphocytesTumor EscapeAnimalsMiceHumansCTLA-4 AntigenFemaleMice, Inbred C57BL

Substanzen

Histocompatibility Antigens Class ICTLA-4 Antigen

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, University of Minnesota Medical School, Minneapolis, MN, USA.
  • Center for Immunology, University of Minnesota Medical School, Minneapolis, MN, USA.
  • Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
  • Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.
  • Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada.
  • Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.

ORCID-Profile: Zoe C Schmiechen, Eduardo Cruz-Hinojoza, Audrey L Hilk, Alexander K Tsai, Olivia M Dres, Liang-I Kang, Michael J Geuenich, Jonah Z Butler, Adam L Burrack, Grant H Hickok, Cara-Lin Lonetree, Rachana Pandey, Hezkiel A Nanda, Indrajit Chaudhury, Thamotharampillai Dileepan, Steven S Shen, Kieran R Campbell, David G DeNardo, Ingunn M Stromnes

Förderung

  • NIGMS NIH HHS
  • National Institutes of Health
  • AACR-Pancreatic Action Network
  • American Cancer Society
  • U.S. Department of Defense
  • Pancreatic Cancer Action Network
  • Canadian Institutes of Health Research
  • Natural Sciences and Engineering Research Council of Canada Discovery

Zitieren

APA

Schmiechen, Z. C., Cruz-Hinojoza, E., Hilk, A. L., Ellefson, M. A., Tsai, A. K., Dres, O. M., Kang, L. I., Geuenich, M. J., Butler, J. Z., Burrack, A. L., Larsen, B. M., Hickok, G. H., Miller, E. A., Lonetree, C. L., Gaire, A., Pandey, R., Nanda, H. A., Chaudhury, I., Corbiere, T., …, & Stromnes, I. M. (2026). T reg cells promote immunotherapy-induced immune evasion by restraining CD4 T cell control of MHC-I–deficient metastatic pancreatic cancer. Science Immunology, 11(120). https://doi.org/10.1126/sciimmunol.adz4302

Vancouver

Schmiechen ZC, Cruz-Hinojoza E, Hilk AL, Ellefson MA, Tsai AK, Dres OM, et al. T reg cells promote immunotherapy-induced immune evasion by restraining CD4 T cell control of MHC-I–deficient metastatic pancreatic cancer. Science Immunology. 2026;11(120). doi:10.1126/sciimmunol.adz4302

BibTeX
@article{Schmiechen2026,
  author = {Schmiechen, Zoe C and Cruz-Hinojoza, Eduardo and Hilk, Audrey L and Ellefson, Madeline A and Tsai, Alexander K and Dres, Olivia M and Kang, Liang-I and Geuenich, Michael J and Butler, Jonah Z and Burrack, Adam L and Larsen, Brandon M and Hickok, Grant H and Miller, Ebony A and Lonetree, Cara-Lin and Gaire, Amrit and Pandey, Rachana and Nanda, Hezkiel A and Chaudhury, Indrajit and Corbiere, Thomas and Dileepan, Thamotharampillai and Shen, Steven S and Campbell, Kieran R and DeNardo, David G and Stromnes, Ingunn M},
  title = {T reg cells promote immunotherapy-induced immune evasion by restraining CD4 T cell control of MHC-I–deficient metastatic pancreatic cancer},
  journal = {Science Immunology},
  year = {2026},
  volume = {11},
  number = {120},
  doi = {10.1126/sciimmunol.adz4302}
}
Kostenlos starten →